Wednesday, September 9, 2026

Chong Kun Dang Wins European Phase 1 Approval for Dupixent Biosimilar: Advancing CKD-706’s Global Development

Chong Kun Dang's CKD-706 biosimilar for Dupixent received Phase 1 trial approval in Europe, aiming to expand treatment options for inflammatory diseases.

Why the U.S. Navy Seeks Support from South Korea in the Strategic Hormuz Strait

The U.S. Navy's actions in the Strait of Hormuz highlight Iran's naval threats and the need for allied support amid complex geographical challenges.

North Korea Shows Troops in Russia for First Time, Honors War Dead

North Korea publicly displays images of soldiers in Russia, highlighting military cooperation and propaganda efforts by Kim Jong Un.

Tag: Freedom to Operate

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

Mastering U.S. Patent Risks: Essential Training for Korean Life Sciences Firms

The Korea Pharmaceutical and Bio-Pharma Association will host training on U.S. patent risks for local pharma and biotech professionals.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.